MI Brewin Dolphin Voyager Max 70% equity fund 31 January 2021

Investment Objective OK Risk 53-65

The fund aims to deliver capital growth and income through an exposure to equities of up to 70%.

4 5 7

Investment Overview Key Information & Charges

Our investment approach is to utilise the expertise of the best Share class: A Inc and Acc investment managers at the lowest cost to manage the assets. To Benchmark: Investment Association Mixed do this, we invest in other funds to gain access to the specified Investment: 20-60% Shares Sector style or strategy. Fund codes: Bloomberg The fund is actively managed. The mix of investment types will be Inc - MIB7AGI LN Equity, Acc - MIB7AGA LN Equity managed and regularly monitored by our investment team. ISIN: Inc - GB00BLF9V166, Acc - GB00BLF9V059 The primary focus of our research team is to identify a ‘buy list’ of Citicode: thoroughly researched investments from which we select when Inc - BNXC, Acc - BNXD building the funds. Investment research conducted by the team SEDOL: covers all major asset classes spanning all regions of the world as Inc - BLF9V16, Acc - BLF9V05 well as alternative investments. The investment companies from Launch date: 28 October 2020 which we select funds is based on an initial quality screen, which OCF: 0.82 considers factors such as the financial strength, organisational integrity and stability of the investment firm. Team details

Fund manager: Investment solutions team

Key team members:

David Hood Guy Foster

Contact us: [email protected] | 020 3201 3520 MI Brewin Dolphin Voyager | Max 70% equity fund 31 January 2021

Market Commentary

After a tumultuous month, US politics finally saw some stability deteriorated with both the composite PMI and consumer with the Democrats securing a slim majority in the Senate, to go confidence falling. China GDP returned to trend growth driven by along with their control of the House of Representatives, and the the recovery in both domestic and external demand anticipated inauguration of President Joe Biden. Vaccinations Equity markets were down around 1% over January but Asia and began in earnest as countries looked to protect their at-risk Emerging Markets were the areas to buck the trend, up around population, although as the month ended, Europe displayed their 3%. Bonds also fell with UK Gilts and Corporates down between frustrations over delivery delays. Both Novavax & Johnson and 1-2%. Johnson reported good news on their vaccine trials. The UK economy suffered as the market assessed the magnitude of the extended lockdown, whilst in Europe sentiment and growth

Portfolio Holdings as at 31 January 2021 Asset Allocation

MI Select Managers Bond Fund Institutional Income 22.7% 3% MI Select Managers UK Equity Income Fund Inst Inc 13.5% 14.5% 23% MI Select Managers North American Equity Inst Inc 11.7%

Fidelity Index US Fund Inc GBp 8.3% 4% MI Select Managers UK Equity Fund Inst Income 6.1%

Blackrock Continental European Income Inst Inc 4.5%

Mellon Inv - BNY Mellon Asian Income Inst W Inc 3.8%

BNY Mellon Global Dynamic Bond Fund I3I 3.5%

JPM Global Macro Opportunities Fund C Net Inc 3.4% 19.5% Cash 3.1%

Ninety One Diversified Income B Inc GBp 3.0% 36% Janus Henderson UK Absolute Return Fund G Acc 3.0%

Baillie Gifford Overseas Gwth Japanese Fund W1 Inc 2.0% FUNDSMITH EQUITY FUND-I INC 2.0% Bonds Commercial Property Schroder Global Cities Real Estate Units L Inc 1.9% Equities - UK Alternatives Fidelity Investment Funds - Asia Funds W Acc 1.5%

Fidelity Investment Funds Emerging Market W Acc 1.3% Equities - International Cash

BNY Mellon Global Short Dated £ Z Inc Hedged 1.2%

Muzinich Global Tactical Credit H GBP Inc G 1.2%

BlackRock Gold & General Fund DI Inc 0.9%

Man Japan CoreAlpha-D-Inc Fund GBp 0.5%

Hermes Asia Ex Japan Equity Fund Inc 0.5%

iShares Global Property Secs Equity Index L Acc 0.4%

Past performance is not a guide to future performance. The value of investments and any income from them can fall and you may get back less than you invested. If you invest in currencies other than your own, fluctuations in currency value will mean that the value of your investment will move independently of the underlying asset. The information contained in this documentation has been taken from sources stated and is believed to be reliable and accurate, but without further investigation cannot be warranted as to accuracy or completeness. We or a connected person may have positions in or options on the securities mentioned herein or may buy, sell or offer to make a purchase or sale of such securities from time to time. In addition we reserve the right to act as principal or agent with regard to the sale or purchase of any security mentioned in this document. For further information, please refer to our conflicts policy which is available on requestor can be accessed via our website at www.brewin.co.uk. eValuerisk tolerance scores are based on a 10-year time horizon. The mappings are only for use by financial advisers licensed to use eValue’s risk profiling system and does not constitute financial advice. It is the responsibility of the adviser to select the correct model appropriate for the client’s time horizon and objective. The opinions expressed are not necessarily the views held throughout Brewin Dolphin Ltd. © FinaMetricaPty Ltd. Risk tolerance scores were mapped to the funds’ strategic asset allocations as at 01/05/2020. The mappings are only for use by financial advisers licensed to use FinaMetrica’s risk profiling system and do not constitute financial advice. Financial advisers must satisfy themselves that the funds’ current asset allocations reflect the risk/return expectations of the funds when mapped. Brewin Dolphin Limited is a member of the Stock Exchange, and is authorised and regulated by the Financial Conduct Authority (Financial Services Register reference number: 124444).

BDM3175_2102_0.3